Investec Bank plc has filed a public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure, filed on 1st July 2026, covers dealings undertaken by Investec as an exempt principal trader with recognised intermediary status acting in a client-serving capacity.
Investec serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the filing.
The dealings were carried out on 30th June 2026, with Investec transacting in ordinary shares of Advanced Medical Solutions Group across both purchase and sale positions.
On the purchase side, Investec acquired a total of 1,252,666 ordinary shares, with prices ranging from a low of 279.5p to a high of 280p per unit.
On the sales side, Investec disposed of 1,302,983 ordinary shares within the same price range of 279.5p to 280p per unit.
The volume of shares sold slightly exceeded the volume purchased, reflecting typical market-making activity conducted by an exempt principal trader operating in a client-serving capacity.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were exercised or written in connection with this disclosure.
Investec confirmed there are no indemnity arrangements, options, or agreements that could serve as inducements to deal or refrain from dealing with any party to the offer.
The bank also confirmed no agreements or understandings exist relating to voting rights or future acquisitions tied to any derivative instruments referencing Advanced Medical Solutions Group securities.
The disclosure was prepared by contact Priyali Bhattacharjee, and public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service.
The Takeover Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code.
